Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 90


Challenges With Acute Care and Response to Treatment Among Adult Patients With Cyclic Vomiting Syndrome.

Jensen AD.

Gastroenterol Nurs. 2015 Nov-Dec;38(6):469-76. doi: 10.1097/SGA.0000000000000148.


Raster-scanned intensity-controlled carbon ion therapy for mucosal melanoma of the paranasal sinus.

Mohr A, Chaudhri N, Hassel JC, Federspil PA, Vanoni V, Debus J, Jensen AD.

Head Neck. 2016 Apr;38 Suppl 1:E1445-51. doi: 10.1002/hed.24256. Epub 2015 Nov 11.


COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.

Jensen AD, Nikoghosyan AV, Lossner K, Haberer T, Jäkel O, Münter MW, Debus J.

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):37-46. doi: 10.1016/j.ijrobp.2015.05.013. Epub 2015 May 19.


High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.

Jensen AD, Poulakis M, Nikoghosyan AV, Welzel T, Uhl M, Federspil PA, Freier K, Krauss J, Höss A, Haberer T, Jäkel O, Münter MW, Schulz-Ertner D, Huber PE, Debus J.

Radiother Oncol. 2016 Feb;118(2):272-80. doi: 10.1016/j.radonc.2015.05.010. Epub 2015 Jul 8.


Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.

Jensen AD, Nikoghosyan AV, Poulakis M, Höss A, Haberer T, Jäkel O, Münter MW, Schulz-Ertner D, Huber PE, Debus J.

Cancer. 2015 Sep 1;121(17):3001-9. doi: 10.1002/cncr.29443. Epub 2015 Jun 4.


Ketene as a Reaction Intermediate in the Carbonylation of Dimethyl Ether to Methyl Acetate over Mordenite.

Rasmussen DB, Christensen JM, Temel B, Studt F, Moses PG, Rossmeisl J, Riisager A, Jensen AD.

Angew Chem Int Ed Engl. 2015 Jun 15;54(25):7261-4. doi: 10.1002/anie.201410974. Epub 2015 May 12.


Carbon Ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheaths tumors: acute toxicity and preliminary outcome.

Jensen AD, Uhl M, Chaudhri N, Herfarth KK, Debus J, Roeder F.

Radiat Oncol. 2015 May 6;10:109. doi: 10.1186/s13014-015-0414-8.


Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.

Jensen AD, Poulakis M, Nikoghosyan AV, Chaudhri N, Uhl M, Münter MW, Herfarth KK, Debus J.

Radiother Oncol. 2015 Feb;114(2):182-8. doi: 10.1016/j.radonc.2015.01.002. Epub 2015 Jan 29.


An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivo.

Kiesgen S, Arndt MA, Körber C, Arnold U, Weber T, Halama N, Keller A, Bötticher B, Schlegelmilch A, Liebers N, Cremer M, Herold-Mende C, Dyckhoff G, Federspil PA, Jensen AD, Jäger D, Kontermann RE, Mier W, Krauss J.

Cancer Lett. 2015 Feb 1;357(1):364-73. doi: 10.1016/j.canlet.2014.11.054. Epub 2014 Nov 27.


One-step synthesis of bismuth molybdate catalysts via flame spray pyrolysis for the selective oxidation of propylene to acrolein.

Schuh K, Kleist W, Høj M, Trouillet V, Jensen AD, Grunwaldt JD.

Chem Commun (Camb). 2014 Dec 18;50(97):15404-6. doi: 10.1039/c4cc07527g. Epub 2014 Oct 28.


Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol.

Uhl M, Edler L, Jensen AD, Habl G, Oelmann J, Röder F, Jäckel O, Debus J, Herfarth K.

Radiat Oncol. 2014 Apr 29;9:100. doi: 10.1186/1748-717X-9-100.


High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term results.

Uhl M, Mattke M, Welzel T, Oelmann J, Habl G, Jensen AD, Ellerbrock M, Haberer T, Herfarth KK, Debus J.

Cancer. 2014 May 15;120(10):1579-85. doi: 10.1002/cncr.28606. Epub 2014 Feb 5.


Cell mass and cell cycle dynamics of an asynchronous budding yeast population: experimental observations, flow cytometry data analysis, and multi-scale modeling.

Lencastre Fernandes R, Carlquist M, Lundin L, Heins AL, Dutta A, Sørensen SJ, Jensen AD, Nopens I, Lantz AE, Gernaey KV.

Biotechnol Bioeng. 2013 Mar;110(3):812-26. doi: 10.1002/bit.24749. Epub 2012 Nov 12.


Treatment of squamous cell carcinoma of the mobile tongue or tongue margins: an interdisciplinary challenge.

Hauswald H, Zwicker F, Rochet N, Jensen AD, Debus J, Lindel K.

Acta Oncol. 2013 Jun;52(5):1017-21. doi: 10.3109/0284186X.2012.722678. Epub 2012 Sep 15.


IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.

Jensen AD, Nikoghosyan AV, Lossner K, Herfarth KK, Debus J, Münter MW.

BMC Cancer. 2012 May 2;12:163. doi: 10.1186/1471-2407-12-163.


Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.

Jensen AD, Krauss J, Potthoff K, Simon C, Nikoghosyan AV, Lossner K, Debus J, Münter MW.

Radiat Oncol. 2012 Apr 2;7:57. doi: 10.1186/1748-717X-7-57.


Isometric muscle training of the spine musculature in patients with spinal bony metastases under radiation therapy.

Rief H, Jensen AD, Bruckner T, Herfarth K, Debus J.

BMC Cancer. 2011 Nov 9;11:482. doi: 10.1186/1471-2407-11-482.


Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.

Jensen AD, Nikoghosyan AV, Ecker S, Ellerbrock M, Debus J, Herfarth KK, Münter MW.

Radiat Oncol. 2011 Nov 2;6:149. doi: 10.1186/1748-717X-6-149.


Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Jensen AD, Krauss J, Weichert W, Bergmann ZP, Freier K, Debus J, Münter MW.

Radiat Oncol. 2011 Sep 23;6:122. doi: 10.1186/1748-717X-6-122.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk